Page last updated: 2024-09-04

gl 331 and Stomach Neoplasms

gl 331 has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, JY; Chao, Y; Chen, JD; Chen, LT; Lan, C; Li, AF; Lin, WC; Liu, JM; Liu, TS; Shiah, HS; Whang-Peng, J; Wu, CW; Wu, HW1

Trials

1 trial(s) available for gl 331 and Stomach Neoplasms

ArticleYear
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients.
    Cancer chemotherapy and pharmacology, 2002, Volume: 49, Issue:5

    Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Stomach Neoplasms; Survival Analysis

2002